F. Bieri
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Peroxisome Proliferator-Activated Receptors 17
- Oncology 10
- Drug Transport and Resistance Mechanisms 10
- Co-authors
- W. Stäubli (27 shared papers)P. Bentley (25 shared papers)Felix Waechter (11 shared papers)Samar F. Muakkassah-Kelly (13 shared papers)F. Waechter (17 shared papers)Étienne-Émile Baulieu (1 shared paper)Ariel Orellana (1 shared paper)Alfred Völkl (1 shared paper)
- Journals
- Carcinogenesis (4 papers)Biochemical Pharmacology (3 papers)Toxicology in Vitro (3 papers)Experimental Cell Research (2 papers)Food and Chemical Toxicology (2 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
F. Bieri
30 papers receiving 616 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 166
- Biochemistry 118
- Clinical Biochemistry 99
- Hepatology 62
- Cancer Research 103
Countries citing papers authored by F. Bieri
This map shows the geographic impact of F. Bieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bieri more than expected).
Fields of papers citing papers by F. Bieri
This network shows the impact of papers produced by F. Bieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bieri. The network helps show where F. Bieri may publish in the future.
Co-authors
The 23 scholars most cited alongside F. Bieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 82 | |
| 2 | 1989 | 65 | |
| 3 | 1987 | 61 | |
| 4 | 1983 | 54 | |
| 5 | 1990 | 54 | |
| 6 | 1984 | 53 | |
| 7 | 1971 | 33 | |
| 8 | 1984 | 28 | |
| 9 | 1989 | 27 | |
| 10 | 1988 | 21 | |
| 11 | 1988 | 20 | |
| 12 | 1988 | 20 | |
| 13 | 1988 | 16 | |
| 14 | 1990 | 13 | |
| 15 | 1993 | 13 | |
| 16 | 1988 | 12 | |
| 17 | 1988 | 12 | |
| 18 | 1987 | 10 | |
| 19 | 1991 | 9 | |
| 20 | 1990 | 9 |
About F. Bieri
F. Bieri is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Clinical Biochemistry, having authored 31 papers that have together received 666 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (17 papers), Drug Transport and Resistance Mechanisms (10 papers), Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Metabolism and Genetic Disorders (4 papers), Adipose Tissue and Metabolism (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Pharmacology (166 citations), Biochemistry (118 citations), Clinical Biochemistry (99 citations), Hepatology (62 citations) and Cancer Research (103 citations). F. Bieri has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include W. Stäubli, P. Bentley, Felix Waechter, Samar F. Muakkassah-Kelly, F. Waechter, Étienne-Émile Baulieu, Ariel Orellana, Alfred Völkl, Miguel Bronfman and H. Dariush Fahimi. Their work appears in journals such as Carcinogenesis, Biochemical Pharmacology, Toxicology in Vitro, Experimental Cell Research and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.